Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

KRBP Kiromic BioPharma Inc

0,60

0,00 (0,00%)

17 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Kiromic BioPharma Charts.

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Kiromic BioPharma Charts.

News Kiromic BioPharma Inc

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Donnerstag 19 September 2024 (4 Monate vor) • Business Wire

Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous Recommendation
Donnerstag 19 September 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 21 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
Mittwoch 14 August 2024 (5 Monate vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 9 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial
Freitag 9 August 2024 (5 Monate vor) • Business Wire

Kiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01
Donnerstag 1 August 2024 (6 Monate vor) • Business Wire

Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase
Donnerstag 18 Juli 2024 (6 Monate vor) • Business Wire

Form 8-K - Current report
Freitag 28 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 27 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial
Donnerstag 20 Juni 2024 (7 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 14 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Weitere Kiromic BioPharma Inc News-Artikel

Antin Infrastructure Par... (PK)

London City Equities

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen